Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1074 | 957 | 1223 | 881 | 1193 | 1729 |
Fund Return | 7.36% | -4.3% | 22.25% | -4.13% | 3.59% | 5.63% |
Place in category | 427 | 577 | 40 | 552 | 412 | 195 |
% in Category | 66 | 83 | 5 | 95 | 83 | 66 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
B Multistock Swiss Stock Fund CHF A | 43.61M | 7.07 | -1.53 | 7.32 | ||
B Multistock Swiss Stock Fund CHF B | 109.77M | 7.07 | -1.53 | 7.31 | ||
B Multistock Swiss Stock Fund CHF C | 17.59M | 7.74 | -0.79 | 8.12 | ||
Multiflex S Carnot Efficient Energc | 95.18M | -1.03 | -4.96 | 3.14 | ||
Popso Suisse Investment Fund S Glob | 92.87M | 5.68 | -0.63 | 2.15 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.38B | 9.01 | 1.94 | 5.88 | ||
Raiffeisen Futura Swiss Stock A | 2.17B | 7.81 | -1.29 | 5.90 | ||
UBS CH Equity Fund Swiss Income CHF | 2.1B | 9.72 | 2.91 | 5.73 | ||
UBS CH Equity Fund Swiss Income CHQ | 2.1B | 10.36 | 3.55 | 6.38 | ||
CH0502155648 | 2.02B | 9.21 | 2.75 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novartis | CH0012005267 | 6.36 | 88.82 | +1.30% | |
Roche Holding Participation | CH0012032048 | 6.14 | 253.60 | +1.04% | |
Nestle | CH0038863350 | 5.92 | 74.42 | +0.46% | |
Straumann Holding AG | CH1175448666 | 5.29 | 114.85 | +0.53% | |
Partners Group | CH0024608827 | 5.03 | 1,233.00 | +1.23% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Sell |
Technical Indicators | Sell | Strong Sell | BUY |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review